|
|
||||||||
American Journal of Clinical Nutrition, Vol 44, 986-995, Copyright © 1986 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
N Freinkel, DL Cockroft, NJ Lewis, L Gorman, S Akazawa, LS Phillips and GE Shambaugh 3d
Whole rat embryos were explanted at head-fold, late pre-somite stage (day 9.5 of gestation) and cultured in rat sera varyingly supplemented with glucose (3, 6, 9, or 12 mg/mL), D,L sodium beta-hydroxybutyrate (2, 4, 8, or 16 mM), or both (6 mg/mL D-glucose plus 8 mM beta- hydroxybutyrate). During 48 h culture, increasing glucose alone or beta- hydroxybutyrate alone effected growth retardation and faulty neural and extraneural organogenesis in dose-dependent fashion. Synergistic dysmorphogenic effects occurred when minimally teratogenic concentrations of glucose and beta-hydroxybutyrate were combined. Sera from diabetic animals containing somatomedin inhibitor bioactivity were also able to produce growth retardation and major developmental lesions in presence of amounts of glucose and ketones which of themselves were not teratogenic. Thus, aberrant fuels and fuel-related products can impair growth and organogenesis in early post-implantation embryo. Such fuel-mediated teratogenesis may be multifactorial and include possibilities for synergistic and additive interactions.
This article has been cited by other articles:
![]() |
A. K. Nath, J. Enciso, M. Kuniyasu, X.-Y. Hao, J. A. Madri, and E. Pinter Nitric oxide modulates murine yolk sac vasculogenesis and rescues glucose induced vasculopathy Development, May 15, 2004; 131(10): 2485 - 2496. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Reece, C. J. Homko, Y.-K. Wu, and A. Wiznitzer The Role of Free Radicals and Membrane Lipids in Diabetes-Induced Congenital Malformations Reproductive Sciences, July 1, 1998; 5(4): 178 - 187. [Abstract] [PDF] |
||||
![]() |
K. H. Moley, M. M.-Y. Chi, and M. M. Mueckler Maternal hyperglycemia alters glucose transport and utilization in mouse preimplantation embryos Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E38 - E47. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |